Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
DNase I (RNase-free): Precision Tools for Cancer Stem Cell A
2026-05-18
Explore how DNase I (RNase-free) enables robust DNA removal for RNA extraction and advanced cancer stem cell research. This article uniquely bridges enzyme biochemistry with translational applications in tumor biology.
-
Data-Driven Design of Optimized Kinase Inhibitor Libraries
2026-05-18
Moret et al. (2019) introduce a robust cheminformatics framework for analyzing and constructing small-molecule libraries, with a focus on selectivity and target coverage. Their approach enables the development of compact, highly selective kinase inhibitor collections, optimizing chemical biology experiments and drug discovery workflows.
-
Optimizing Colitis Models with Dextran Sulfate Sodium Salt (
2026-05-17
Dextran sulfate sodium salt (MW 35000-45000) elevates the precision of mouse models in ulcerative colitis research by enabling reproducible induction of colonic epithelial injury. This article delivers proven protocol enhancements, troubleshooting strategies, and practical insights for leveraging DSS in advanced studies of intestinal inflammation and mucosal repair.
-
Q-VD-OPh: Potent Pan-Caspase Inhibitor for Apoptosis Researc
2026-05-16
Q-VD-OPh is a highly selective, irreversible pan-caspase inhibitor used to dissect apoptotic pathways in vitro and in vivo. It targets multiple caspases at nanomolar potency and enhances cell viability, especially post-cryopreservation. Its utility spans apoptosis research and neurodegenerative disease models.
-
Linoleic Acid Drives Tumor Progression in pLELC via PPARα–TF
2026-05-15
This study reveals that linoleic acid (LA) promotes tumor progression in primary pulmonary lymphoepithelioma-like carcinoma (pLELC) by upregulating tissue factor (TF) expression through the PPARα pathway. Multiomics profiling and xenograft model validation highlight the central role of the LA–PPARα–TF signaling axis, suggesting TF as a promising therapeutic target for this rare lung cancer.
-
PAD4-IN-2 TFA: Precision Inhibition of H3 Citrullination in
2026-05-15
PAD4-IN-2 TFA, a meta-phenylboronic acid-modified PAD4 inhibitor, delivers high tumor selectivity and robust inhibition of histone H3 citrullination and NET formation. Unlock advanced immune microenvironment modulation and antitumor efficacy with state-of-the-art workflow guidance and troubleshooting tips tailored for bench scientists.
-
N6-Methyl-dATP: Advancing Epigenetics from Mechanism to Clin
2026-05-14
This thought-leadership article examines the mechanistic, experimental, and translational dimensions of N6-Methyl-dATP, spotlighting its role as a precision probe for DNA replication fidelity and epigenetic regulation. By integrating emerging insights into the LMO2/LDB1 oncogenic axis in AML, current best practices for workflow optimization, and a comparative landscape analysis, the article delivers strategic guidance for researchers aiming to bridge discovery and clinical innovation. The discussion showcases APExBIO’s N6-Methyl-dATP (SKU B8093) as a next-generation tool, emphasizing its unique methylation profile and translational promise in genomic stability and targeted drug design.
-
Cabozantinib (XL184): Advanced Workflows in RCC Signaling Re
2026-05-14
Leverage Cabozantinib (XL184) for timescale-dependent phosphoproteomic dissection and antiangiogenic modeling in renal cell carcinoma. This guide details experimental enhancements, troubleshooting, and practical insights directly informed by recent systems-level studies.
-
Cefepime (BMY-28142): Neurotoxicity, CNS Models, and Assay P
2026-05-13
Explore how Cefepime (BMY-28142) empowers advanced neurotoxicity studies and central nervous system infection models. This in-depth guide reveals best practices, mechanistic insights, and protocol parameters for rigorous research applications.
-
25-Hydroxycholesterol Orchestrates Macrophage Immunometaboli
2026-05-13
Xiao et al. (2024) reveal how 25-hydroxycholesterol accumulates in tumor-associated macrophages, activating AMPKα via a lysosomal pathway to drive immunosuppressive polarization and limit antitumor immunity. Their mechanistic insights spotlight CH25H as a metabolic checkpoint, with translational relevance for immunotherapy combinations.
-
Q-VD(OMe)-OPh: Precise Caspase Inhibition for Apoptosis Assa
2026-05-12
Q-VD(OMe)-OPh redefines apoptosis research with broad-spectrum, non-toxic caspase inhibition and robust reproducibility in both in vitro and in vivo models. Its superior potency and workflow flexibility empower advanced studies in cancer resistance and neuroprotection, outperforming legacy inhibitors.
-
Lactate Drives HMGB1 Modification and Exosomal Release in Se
2026-05-12
This study reveals that lactate actively promotes both lactylation and acetylation of HMGB1 in macrophages during polymicrobial sepsis, leading to enhanced exosomal release and increased endothelial permeability. These findings highlight lactate-associated pathways as potential therapeutic targets in inflammatory signaling and sepsis intervention.
-
Azathramycin A: Precision Tool for Protein Synthesis Inhibit
2026-05-11
Explore Azathramycin A, a macrolide antibiotic uniquely suited for probing Mycobacterium tuberculosis protein synthesis inhibition and resistance mechanisms. This article delivers advanced analytical guidance for assay design and resistance modeling.
-
Pregnenolone Carbonitrile: PXR Agonist for Hepatic and Water
2026-05-11
Pregnenolone Carbonitrile (PCN) extends beyond classic xenobiotic metabolism studies, enabling precise control over hepatic detoxification and water balance pathways. Learn how this gold-standard PXR agonist empowers advanced experimental designs, with actionable troubleshooting and best-practice insights for robust, reproducible results.
-
HBTU in Peptide Bond Formation: Workflow, Performance & Tips
2026-05-10
HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate) is a gold-standard peptide coupling reagent, enabling high-yield, racemization-resistant synthesis even for complex and enzyme-responsive peptides. This guide translates current research advances into practical workflows, protocol optimizations, and troubleshooting strategies for researchers seeking robust peptide bond formation.
8767 records 12/585 page Previous Next First page 上5页 1112131415 下5页 Last page